, Volume 52, Issue 1, pp 46–53 | Cite as

The association of obesity with hearing thresholds in women aged 18–40 years

  • Rıfkı Üçler
  • Mahfuz Turan
  • Fatih Garça
  • İsmail Acar
  • Murat Atmaca
  • Hakan Çankaya
Original Article


An elevation in hearing thresholds and decrease in hearing sensitivity in adults, particularly due to aging, are quite common. Recent studies have shown that, apart from aging, various other factors also play a role in auditory changes. Studies on the association of hearing loss (HL) with obesity are limited in advanced age cases and present contradictions. In this study, the association between obesity and hearing thresholds in women aged 18–40 years has been assessed. Forty women diagnosed with obesity (mean age, 31.8 years) and 40 healthy non-obese female controls (mean age, 30.5 years) were included in this prospective study. Each subject was tested with low (250, 500, 1000 and 2000 Hz) and high (4000, 6000 and 8000 Hz) frequency audiometry. In the case and control groups, the average hearing thresholds at low frequencies were 16.03 ± 4.72 and 16.15 ± 2.72 (p = 0.885) for the right ear, respectively, and 16.15 ± 5.92 and 14.71 ± 3.18 (p = 0.180) for the left ear, respectively. The average hearing threshold levels at high frequencies were 20.70 ± 10.23 and 15.33 ± 3.87 (p = 0.003), respectively, for the right ear, and 22.91 ± 15.54 and 15.87 ± 4.35 (p = 0.007), respectively, for the left ear with statistical significance. This is the first report on the association of obesity with hearing threshold in women aged 18–40 years. We have demonstrated that obesity may affect hearing function, particularly that related to high frequencies. Hearing loss can be prevented by avoidance or control of obesity and its risk factors. Moreover, an auditory screening of obese cases at an early stage may provide early diagnosis of HL and may also contribute to their awareness in the fight against obesity.


Obesity Audiometry Hearing loss Body mass index 


Compliance with ethical standards

Conflict of interest



  1. 1.
    J.R. Pleis, M. Lethbridge-Cejku, Summary health statistics for U.S. adults: National Health Interview Survey, 2006. Vital Health Stat 10 235, 1–153 (2007)PubMedGoogle Scholar
  2. 2.
    Y. Agrawal, E.A. Platz, J.K. Niparko, Prevalence of hearing loss and differences by demographic characteristics among US adults: data from the National Health and Nutrition Examination Survey, 1999-2004. Arch. Intern. Med. 168, 1522–1530 (2008)CrossRefPubMedGoogle Scholar
  3. 3.
    G.A. Gates, J.H. Mills, Presbycusis. Lancet 366, 1111–1120 (2005)CrossRefPubMedGoogle Scholar
  4. 4.
    J. Shargorodsky, S.G. Curhan, R. Eavey, G.C. Curhan, A prospective study of cardiovascular risk factors and incident hearing loss in men. Laryngoscope 120, 1887–1891 (2010)CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    O.A. Sogebi, Assessment of the risk factors for hearing loss in adult Nigerian population. Niger. Med. J. 54, 244–249 (2013)CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    C. Kucur, S.K. Kucur, I. Gozukara, A. Seven, K.B. Yuksel, N. Keskin, F. Oghan, Extended high frequency audiometry in polycystic ovary syndrome. Sci. World J. 2013, 482689 (2013)CrossRefGoogle Scholar
  7. 7.
    J.W. Hong, J.H. Jeon, C.R. Ku, J.H. Noh, H.J. Yoo, D.J. Kim, The prevalence and factors associated with hearing impairment in the Korean adults: the 2010-2012 Korea National Health and Nutrition Examination Survey (observational study). Medicine 94, 611 (2015)CrossRefGoogle Scholar
  8. 8.
    M.A. Musani, A. Rauf, M. Ahsan, F.A. Khan, Frequency and causes of hearing impairment in tertiary care center. J. Pak. Med. Assoc. 61, 141–144 (2011)PubMedGoogle Scholar
  9. 9.
    A. Arduc, S. Isık, S. Allusoglu, A. Iriz, B.A. Dogan, C. Gocer, M.M. Tuna, D. Berker, S. Guler, Evaluation of hearing functions in patients with euthyroid Hashimoto’s thyroiditis. Endocrine (2015). doi: 10.1007/s12020-015-0624-8 PubMedGoogle Scholar
  10. 10.
    D. Berker, H. Karabulut, S. Isik, Y. Tutuncu, U. Ozuguz, G. Erden, Y. Aydin, M. Dagli, S. Guler, Evaluation of hearing loss in patients with Graves’ disease. Endocrine 41, 116–121 (2012)CrossRefPubMedGoogle Scholar
  11. 11.
    A.W. Jackson, D.C. Lee, X. Sui, J.R. Morrow Jr, T.S. Church, A.L. Maslow, S.N. Blair, Muscular strength is inversely related to prevalence and incidence of obesity in adult men. Obesity 18, 1988–1995 (2010)CrossRefPubMedGoogle Scholar
  12. 12.
    C. Kabrhel, R. Varraso, S.Z. Goldhaber, E.B. Rimm, C.A. Camargo, Prospective study of BMI and the risk of pulmonary embolism in women. Obesity 17, 2040–2046 (2009)CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    J.E. Schaffer, Lipotoxicity: when tissues overeat. Curr. Opin. Lipidol. 14, 281–287 (2003)CrossRefPubMedGoogle Scholar
  14. 14.
    A.K. Lalwani, K. Katz, Y.H. Liu, S. Kim, M. Weitzman, Obesity is associated with sensorineural hearing loss in adolescents. Laryngoscope 123, 3178–3184 (2013)CrossRefPubMedGoogle Scholar
  15. 15.
    T.S. Kim, S.W. Park, Y. Kim do, E.B. Kim, J.W. Chung, H.S. So, Visceral adipose tissue is significantly associated with hearing thresholds in adult women. Clin. Endocrinol. 80, 368–375 (2014)CrossRefGoogle Scholar
  16. 16.
    J.H. Hwang, C.C. Wu, C.J. Hsu, T.C. Liu, W.S. Yang, Association of central obesity with the severity and audiometric configurations of age-related hearing impairment. Obesity 17, 1796–1801 (2009)CrossRefPubMedGoogle Scholar
  17. 17.
    J.H. Hwang, F.Y. Tseng, T.C. Liu, W.S. Yang, No association between plasma adiponectin levels and central auditory function in adults. Metab. Brain Dis. 30, 191–196 (2015)CrossRefPubMedGoogle Scholar
  18. 18.
    J.H. Hwang, C.J. Hsu, T.C. Liu, W.S. Yang, Association of plasma adiponectin levels with hearing thresholds in adults. Clin. Endocrinol. 75, 614–620 (2011)CrossRefGoogle Scholar
  19. 19.
    Clinical Guidelines on the Identification, Evaluation, and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health. Obes Res. 6(Suppl 2), 51S–209S (1998)Google Scholar
  20. 20.
    A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr, D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright Jr, E.J. Roccella, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289, 2560–2572 (2003)CrossRefPubMedGoogle Scholar
  21. 21.
    P.S. Jellinger, D.A. Smith, A.E. Mehta, O. Ganda, Y. Handelsman, H.W. Rodbard, M.D. Shepherd, J.A. Seibel, A.A.C.E. Task, Force for Management of Dyslipidemia and Prevention of Atherosclerosis. American Association of Clinical Endocrinologists’ Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocr. Pract. 18(Suppl 1), 1–78 (2012)CrossRefPubMedGoogle Scholar
  22. 22.
    American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1), S62–S69 (2010)CrossRefPubMedCentralGoogle Scholar
  23. 23.
    D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)CrossRefPubMedGoogle Scholar
  24. 24.
    J.F. Ascaso, S. Pardo, J.T. Real, R.I. Lorente, A. Priego, R. Carmena, Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 26, 3320–3325 (2003)CrossRefPubMedGoogle Scholar
  25. 25.
    L.A. Campfield, F.J. Smith, The pathogenesis of obesity. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 13, 13–30 (1999)CrossRefPubMedGoogle Scholar
  26. 26.
    L.C. Hwang, C.H. Bai, C.J. Chen, Prevalence of obesity and metabolic syndrome in Taiwan. J. Formos. Med. Assoc. 105, 626–635 (2006)CrossRefPubMedGoogle Scholar
  27. 27.
    O.P. Tandon, F. Khaliq, N. Goel, Auditory evoked potential responses in menopausal women: a normative study. Indian J. Physiol. Pharmacol. 45, 361–366 (2001)PubMedGoogle Scholar
  28. 28.
    J.H. Hwang, J.C. Chao, H.C. Ho, S.H. Hsiao, Effects of sex, age and hearing asymmetry on the interaural differences of auditory brainstem responses. Audiol. Neurotol. 13, 29–33 (2008)CrossRefGoogle Scholar
  29. 29.
    C.G. Le Prell, C. Spankovich, E. Lobariñas, S.K. Griffiths, Extended high-frequency thresholds in college students: effects of music player use and other recreational noise. J. Am. Acad. Audiol. 24, 725–739 (2013)CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    D. Sharma, S.K. Munjal, N.K. Panda, Extended high frequency audiometry in secretory otitis media. Indian J. Otolaryngol. Head Neck Surg. 64, 145–149 (2012)CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    I. Majumdar, L.D. Mastrandrea, Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome. Endocrine 41, 442–449 (2012)CrossRefPubMedGoogle Scholar
  32. 32.
    J.H. Hwang, C.J. Hsu, W.H. Yu, T.C. Liu, W.S. Yang, Diet-induced obesity exacerbates auditory degeneration via hypoxia, inflammation, and apoptosis signaling pathways in CD/1 mice. PLoS One 8, e60730 (2013)CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    W.S. Yang, W.J. Lee, T. Funahashi, S. Tanaka, Y. Matsuzawa, C.L. Chao, C.L. Chen, T.Y. Tai, L.M. Chuang, Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J. Clin. Endocrinol. Metab. 86, 3815–3819 (2001)CrossRefPubMedGoogle Scholar
  34. 34.
    S.H. Chu, M.K. Lee, K.Y. Ahn, J.A. Im, M.S. Park, D.C. Lee, J.Y. Jeon, J.W. Lee, Chemerin and adiponectin contribute reciprocally to metabolic syndrome. PLoS One 7, e34710 (2012)CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    K.G. Alberti, P. Zimmet, J. Shaw, Metabolic syndrome—a new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet. Med. 23, 469–480 (2006)CrossRefPubMedGoogle Scholar
  36. 36.
    C.A. Maia, C.A. Campos, Diabetes mellitus as etiological factor of hearing loss. Rev. Bras. Otorrinolaringol. (Engl Ed). 71, 208–214 (2005)CrossRefGoogle Scholar
  37. 37.
    S.T. Frisina, F. Mapes, S. Kim, D.R. Frisina, R.D. Frisina, Characterization of hearing loss in aged type II diabetics. Hear. Res. 211, 103–113 (2006)CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    B. Satar, Y. Ozkaptan, H.S. Sürücü, H. Oztürk, Ultrastructural effects of hypercholesterolemia on the cochlea. Otol Neurotol. 22, 786–789 (2001)CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Rıfkı Üçler
    • 1
  • Mahfuz Turan
    • 2
  • Fatih Garça
    • 2
  • İsmail Acar
    • 3
  • Murat Atmaca
    • 1
  • Hakan Çankaya
    • 2
  1. 1.Department of Endocrinology and Metabolism, Faculty of MedicineYuzuncu Yil UniversityVanTurkey
  2. 2.Department of Otorhinolaryngology, Faculty of MedicineYuzuncu Yil UniversityVanTurkey
  3. 3.Department of Internal Medicine, Faculty of MedicineYuzuncu Yil UniversityVanTurkey

Personalised recommendations